Assessment of inactive, active and mixed atherosclerotic plaques by 18F-FDG-PET; an age group-based correlation with cardiovascular risk factors

International Journal of Cardiovascular Imaging

Volumn 25, Issue 2, 2009, Pages 133-140

  Wassélius, Johan ^a   Larsson, Stig ^a   Sundin, Anders ^a   Jacobsson, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

18F FDG PET CT; Atherosclerosis; Cardiovascular imaging; High risk plaque; Nuclear medicine

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IOVERSOL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOPHARMACEUTICALS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 59149090701     PISSN: 15695794     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10554-008-9366-5     Document Type: Article

References (18)

1. Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868-874. doi: 10.1038/nature01323
2. Spagnoli LG, Bonanno E, Sangiorgi G et al (2007) Role of inflammation in atherosclerosis. J Nucl Med 48(11):1800-1815. doi: 10.2967/ jnumed.107.038661
3. Davies MJ (1995) Stability and instability: Two faces of coronary atherosclerosis. The Paul Dudley White Lecture. Circulation 94:2013-2020
4. Fishbein MC, Siegel RJ (1996) How big are coronary atherosclerotic plaques that rupture? Circulation 94(10):2662-2666
5. Libby P (2006) Atherosclerosis: Disease biology affecting the coronary vasculature. Am J Cardiol 98(12A):3Q-9Q. doi: 10.1016/ j.amjcard.2006.09.020
6. Tang T, Howarth SP, Miller SR et al (2006) Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 37(9):2266-2270. doi: 10.1161/01.STR.0000236063.47539.99
7. Saam T, Yuan C, Chu B et al (2007) Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis 194(2):e34-e42. doi: 10.1016/ j.atherosclerosis.2006.08.016
8. Hyafil F, Cornily JC, Feig JE et al (2007) Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 13(5):636-641. doi: 10.1038/nm1571
9. Bleeker-Rovers CP, Bredie SJ, van der Meer JW et al (2003) F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 61(10):323-329
10. Blockmans D, De Ceuninck L, Vanderschueren S et al (2007) Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: A prospective study in 35 patients. Rheumatology (Oxford) 46(4):672-677. doi: 10.1093/rheumatology/kel376
11. Lederman RJ, Raylman RR, Fisher SJ et al (2001) Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun 22(7):747-753. doi: 10.1097/ 00006231-200107000-00004
12. Ogawa M, Ishino S, Mukai T et al (2004) (18)F-FDG accumulation in atherosclerotic plaques: Immunohistochemical and PET imaging study. J Nucl Med 45(7):1245-1250
13. Rudd JH, Warburton EA, Fryer TD et al (2005) Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105(23):2708-2711. doi: 10.1161/ 01.CIR.0000020548.60110.76
14. Davies JR, Rudd JH, Fryer TD et al (2005) Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxy-glucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 36(12):2642-2647. doi: 10.1161/ 01.STR.0000190896.67743.b1
15. Tawakol A, Migrino RQ, Bashian GG et al (2006) In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48(9):1818-1824. doi: 10.1016/j.jacc.2006.05.076
16. Ben-Haim S, Kupzov E, Tamir A, Israel O (2004) Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med 45(11):1816-1821
17. Dunphy MP, Freiman A, Larson SM et al (2005) Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med 46(8):1278-1284
18. Tahara N, Kai H, Ishibashi M et al (2006) Simvastatin attenuates plaque inflammation: Evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48(9):1825-1831. doi: 10.1016/ j.jacc.2006.03.069